Search papers, labs, and topics across Lattice.
1
0
0
4
This study aims to evaluate the value of geriatric screening among patients aged ≥70 years receiving adjuvant CDK4/6i, focusing on its association with quality of life, toxicity risk, relative dose intensity (RDI), and clinical outcomes.